Furune相关文献与解析，生知库 | 链接生命科学的每一步

Takahata, Yoshifumi; Kasashima, Yuki; Yoshioka, Takuya; Yashiki, Shusei; Kulikauskaite, Justina; Matsuura, Tomoaki; Ohba, Yuki; Hasegawa, Hideaki; Yuri, Naoki; Iwai, Nagisa; Otsu, Nanako; Kitakata, Mikiya; Kitaguchi, Yuta; Furune, Haruki; Omori, Chihiro; Mukai, Mutsumi; Komamura-Kohno, Yuki; Huang, Yi-Ying; Hirose, Matsumi; Koike, Nobuya; Yamada, Yoichi; Nakazawa, Kazuo; Ui-Tei, Kumiko; Sakaki, Yoshiyuki; Numano, Rika; Uriu, Koichiro; Tei, Hajime

发表日期：2026

文献求助收藏

Agranulocytosis Following Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma

肝细胞癌患者接受度伐利尤单抗联合曲美利木单抗治疗后出现粒细胞缺乏症

期刊:Internal Medicine

影响因子:1.1

doi:10.2169/internalmedicine.5910-25

Uchida, Genta; Hiraga, Junji; Morita, Kiyoshi; Takeuchi, Atsufumi; Takashi, Hitomi; Furune, Satoshi; Tsuzuki, Tomoyuki

Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer

多西他赛、顺铂和氟尿嘧啶联合培非格司亭于第3天作为食管癌新辅助化疗方案

期刊:Cancer Medicine

影响因子:3.1

doi:10.1002/cam4.6974

Maeda, Osamu; Furune, Satoshi; Kanda, Mitsuro; Miyata, Kazushi; Shimizu, Dai; Sugita, Shizuki; Nishida, Kazuki; Ando, Masahiko; Kodera, Yasuhiro; Ando, Yuichi

Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer

一项II期研究方案，旨在研究三氟尿苷/替吡嘧啶联合雷莫芦单抗作为晚期胃癌三线或后续治疗方案的疗效和安全性

期刊:Nagoya Journal of Medical Science

影响因子:0.9

doi:10.18999/nagjms.86.1.43

Nakanishi, Koki; Tanaka, Chie; Kanda, Mitsuro; Miyata, Kazushi; Machida, Nozomu; Sakai, Mitsuru; Kobayashi, Daisuke; Teramoto, Hitoshi; Ishiyama, Akiharu; Sato, Bin; Oshima, Takashi; Kajikawa, Masaki; Matsushita, Hidenobu; Ishigure, Kiyoshi; Yamashita, Katsuya; Fujitake, Shinichi; Sueoka, Satoshi; Asada, Takahiro; Shimizu, Dai; Sugita, Shizuki; Kuwatsuka, Yachiyo; Maeda, Osamu; Furune, Satoshi; Murotani, Kenta; Ando, Yuichi; Ebata, Tomoki; Kodera, Yasuhiro

Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer

对于转移性胃癌患者，若初始RECIST评估时CEA > 5.0 ng/mL，则R0切除术后行转化手术的预期较低。

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers15215197

Nakanishi, Koki; Tanaka, Chie; Kanda, Mitsuro; Miyata, Kazushi; Furukawa, Kazuhiro; Maeda, Osamu; Shimizu, Dai; Sugita, Shizuki; Kakushima, Naomi; Furune, Satoshi; Kawashima, Hiroki; Ando, Yuichi; Ebata, Tomoki; Kodera, Yasuhiro

Factors Related to Delayed Adverse Events of Endoscopic Submucosal Dissection in the Duodenum

十二指肠内镜黏膜下剥离术延迟不良事件的相关因素

期刊:Digestive Diseases

影响因子:2.1

doi:10.1159/000522362

Kawamura, Tatsuya; Hirose, Takashi; Kakushima, Naomi; Furukawa, Kazuhiro; Furune, Satoshi; Ishikawa, Eri; Sawada, Tsunaki; Keiko, Maeda; Yamamura, Takeshi; Ishikawa, Takuya; Ohno, Eizaburo; Nakamura, Masanao; Honda, Takashi; Ishigami, Masatoshi; Kawashima, Hiroki; Fujishiro, Mitsuhiro

发表日期：2023

文献求助收藏

Successful prevention of stenosis after circumferential endoscopic resection of esophageal cancer

成功预防食管癌环周内镜切除术后狭窄

期刊:Nagoya Journal of Medical Science

影响因子:0.9

doi:10.18999/nagjms.85.1.134

Tanaka, Hitoshi; Kakushima, Naomi; Muroi, Koichi; Hirose, Takashi; Suzuki, Tomohiko; Suzuki, Takahiro; Hida, Emiko; Hirai, Keiko; Shibata, Hiroyuki; Ito, Nobuhito; Furune, Satoshi; Furukawa, Kazuhiro; Fujishiro, Mitsuhiro

Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan

粪便微生物移植治疗肠易激综合征：日本单中心前瞻性研究

期刊:BMC Gastroenterology

影响因子:2.6

doi:10.1186/s12876-022-02408-5

Hamazaki, Motonobu; Sawada, Tsunaki; Yamamura, Takeshi; Maeda, Keiko; Mizutani, Yasuyuki; Ishikawa, Eri; Furune, Satoshi; Yamamoto, Kenta; Ishikawa, Takuya; Kakushima, Naomi; Furukawa, Kazuhiro; Ohno, Eizaburo; Honda, Takashi; Kawashima, Hiroki; Ishigami, Masatoshi; Nakamura, Masanao; Fujishiro, Mitsuhiro

Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer

曲妥珠单抗治疗HER2阳性复发性胃癌患者出现药物性血小板减少症

期刊:International Cancer Conference Journal

影响因子:0.5

doi:10.1007/s13691-021-00520-z

Takano, Yuko; Furune, Satoshi; Miyai, Yuki; Morita, Sachi; Inoue, Megumi; Shimokata, Tomoya; Sugishita, Mihoko; Mitsuma, Ayako; Maeda, Osamu; Ando, Yuichi

Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

更正：接受纳武利尤单抗治疗的无色素性黑色素瘤患者的白癜风和肿瘤反应

期刊:International Cancer Conference Journal

影响因子:0.5

doi:10.1007/s13691-021-00517-8

Furune, Satoshi; Kondo, Chiaki; Takano, Yuko; Shimokata, Tomoya; Sugishita, Mihoko; Mitsuma, Ayako; Maeda, Osamu; Ando, Yuichi

A Period1 inducer specifically advances circadian clock in mice

Period1诱导剂能特异性地提前小鼠的生物钟。

Agranulocytosis Following Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma

肝细胞癌患者接受度伐利尤单抗联合曲美利木单抗治疗后出现粒细胞缺乏症

Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer

多西他赛、顺铂和氟尿嘧啶联合培非格司亭于第3天作为食管癌新辅助化疗方案

Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer

一项II期研究方案，旨在研究三氟尿苷/替吡嘧啶联合雷莫芦单抗作为晚期胃癌三线或后续治疗方案的疗效和安全性

Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer

对于转移性胃癌患者，若初始RECIST评估时CEA > 5.0 ng/mL，则R0切除术后行转化手术的预期较低。

Factors Related to Delayed Adverse Events of Endoscopic Submucosal Dissection in the Duodenum

十二指肠内镜黏膜下剥离术延迟不良事件的相关因素

Successful prevention of stenosis after circumferential endoscopic resection of esophageal cancer

成功预防食管癌环周内镜切除术后狭窄

Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan

粪便微生物移植治疗肠易激综合征：日本单中心前瞻性研究

Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer

曲妥珠单抗治疗HER2阳性复发性胃癌患者出现药物性血小板减少症

Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

更正：接受纳武利尤单抗治疗的无色素性黑色素瘤患者的白癜风和肿瘤反应